Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Ovarian_Cancer
|
| gptkbp:associated_with |
gptkb:Educational_Institution
research studies clinical trials mental health support awareness campaigns patient advocacy groups exercise guidelines legal considerations support networks dietary recommendations lifestyle modifications financial assistance programs treatment protocols insurance coverage issues long-term follow-up care cancer registries screening guidelines Lynch syndrome families ML H1 gene mutation MS H2 gene mutation MS H6 gene mutation PM S2 gene mutation defective DNA mismatch repair survivorship plans tumor microsatellite instability |
| gptkbp:caused_by |
gptkb:healthcare_organization
ovarian cancer endometrial cancer stomach cancer small intestine cancer urinary tract cancer |
| gptkbp:counseling_services |
affected individuals
at-risk relatives |
| gptkbp:first_described_by |
gptkb:Henry_T._Lynch
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lynch syndrome
|
| gptkbp:investment |
gptkb:healthcare_organization
gptkb:adrenal_cancer gptkb:bile_duct_cancer brain cancer neuroendocrine tumors |
| gptkbp:is_known_for |
gptkb:hereditary_nonpolyposis_colorectal_cancer_(HNPCC)
|
| gptkbp:is_popular_in |
1 in 300 to 1 in 400 individuals
|
| gptkbp:managed_by |
oncologists
surgeons genetic counselors |
| gptkbp:risk_factor |
multiple cancers
|
| gptkbp:screenings |
gptkb:family
|
| gptkbp:social_responsibility |
genetic testing
|
| gptkbp:symptoms |
increased cancer risk
family history of cancer |
| gptkbp:treatment |
gptkb:hospital
gptkb:vaccine surveillance chemotherapy |